Maisons Alfort, France

Jean-Paul Bounine

This inventor holds 1 USPTO granted patent. Top assignee: Rhone-Poulenc Rorer S.a.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Paul Bounine. Retrieved from https://idiyas.com/inventor/jean-paul-bounine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jean-Paul Bounine: Innovator in Pharmaceutical Compositions

Introduction

Jean-Paul Bounine is a notable inventor based in Maisons Alfort, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stabilized compositions that enhance the efficacy of certain drugs.

Latest Patents

Bounine holds a patent for "Stabilized pharmaceutical compositions, with quinupristine." This patent describes a stabilized pharmaceutical composition that includes a combined quinupristine/dalfopristine base. It contains an at least stoichiometric amount of methanesulphonic acid or hydrochloric acid, characterized by a pH range of about 3.5 to about 5. The patent also discloses methods for making and using this stabilized composition.

Career Highlights

Bounine is associated with Rhone-Poulenc Rorer S.A., a company known for its innovative pharmaceutical solutions. His work has contributed to advancements in drug formulation, particularly in improving the stability and effectiveness of pharmaceutical products.

Collaborations

One of his notable collaborators is Guillaume Conrath, with whom he has worked on various projects related to pharmaceutical innovations.

Conclusion

Jean-Paul Bounine's contributions to the field of pharmaceuticals, particularly through his patent on stabilized compositions, highlight his role as an innovator in the industry. His work continues to influence the development of effective pharmaceutical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…